[Skip to Navigation]
January 6, 2015

Perspectives on Cardiovascular Screening

Author Affiliations
  • 1Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
  • 2Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Denmark
  • 3Laboratory of Molecular Cardiology, Department of Cardiology, Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
JAMA. 2015;313(1):31-32. doi:10.1001/jama.2014.16253

Sudden death in young people during competitive sports is devastating and counterintuitive, but fortunately a relatively uncommon event.1 Such athletes epitomize the healthiest and most vigorous element of society, voluntarily participating in activities that the community intuitively considers benign and free of significant mortality risk. Screening of young, healthy, general populations to detect cardiovascular diseases responsible for these deaths has been of intense interest in the physician community and general public at the intersection of cardiology, pediatrics, and family practice with public health policy, and largely involving a variety of complex and relatively uncommon genetic disorders or congenital heart diseases responsible for these sudden and unexpected events.